Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ROBERT D HORMATS Insider Profile
4 Followers
ROBERT D HORMATS, Director at American Tower, holds 7.33K shares in American Tower (Ticker: AMT). Most recently, ROBERT D HORMATS Sold $700 shares of American Tower on May 07, 2024 for an estimated value of 128.45K.
ROBERT D HORMATS has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of ROBERT D HORMATS's holdings
Insider Roles
Director
Roles that ROBERT D HORMATS holds in companies
Most Profitable Insider Trade
The most profitable trade made by ROBERT D HORMATS
ROBERT D HORMATS's Trading History
List of latest transactions for each holding click on a transaction to see ROBERT D HORMATS's performance on stock
You May Also Like
ROBERT D HORMATS insider profile FAQ
What is the percentage of profitable transactions made by ROBERT D HORMATS?
The percentage of profitable transactions made by ROBERT D HORMATS is ―.
What is the average return per transaction made by ROBERT D HORMATS?
The average return per transaction made by ROBERT D HORMATS is ―.
What stocks does ROBERT D HORMATS hold?
ROBERT D HORMATS holds: AMT stocks.
What was ROBERT D HORMATS’s latest transaction?
ROBERT D HORMATS latest transaction was an Informative Sell of $128.45K.
What was ROBERT D HORMATS's most profitable transaction?
ROBERT D HORMATS’s most profitable transaction was an Informative Sell of AMT stock on May 7, 2024. The return on the trade was -8.80%.
What is ROBERT D HORMATS's role in American Tower?
ROBERT D HORMATS's role in American Tower is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.